Antineoplastics, Immunosuppressives and Immunomodulators in Tanzania: NEMLIT medicines, brands and prices
Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) lists 94 medicines under Antineoplastics, Immunosuppressives and Immunomodulators. None of them is on the DukaDawa pharmacy network yet.
Last updated
Which antineoplastics, immunosuppressives and immunomodulators can I get on the DukaDawa pharmacy network?
None of the antineoplastics, immunosuppressives and immunomodulators is on the DukaDawa pharmacy network yet.
Which antineoplastics, immunosuppressives and immunomodulators are on Tanzania's NEMLIT?
The NEMLIT (7th edition, 2026) lists 94 medicines under Antineoplastics, Immunosuppressives and Immunomodulators: 5-fluorouracil, 6-Mercaptopurine, Abiraterone acetate, Adalimumab, Aflibercept, Alfuzosin, Allopurinol and Anastrozole and 85 more.
| Medicine | Level | Listed forms | Page |
|---|---|---|---|
| 5-fluorouracil | S | Injection: 250mg; 500mg; 000mg; | p. 12 |
| 6-Mercaptopurine | S | Tablet: 50 mg oral suspension: 20 mg/mL | p. 12 |
| Abiraterone acetate | S | Tablet: 250mg; 500 mg | p. 12 |
| Adalimumab | S | Injection 40mg/0.8mL, 10mg / 0.2mL | p. 14 |
| Aflibercept | S | Injection: 2mg/0.05ml | p. 13 |
| Alfuzosin | D | Tablet: 10mg | p. 12 |
| Allopurinol | B | Tablet: 100mg; 300mg | p. 12 |
| Anastrozole | S | Tablet: 1mg | p. 12 |
| Antithymocyte globulin (ATG) (rabbit) | S | Injection: 25mg/mL in 5mL | p. 12 |
| Atezolizumab | S | Injection: 60 mg/ml; 125 mg/ml | p. 12 |
| Axitinib | S | Tablet 1mg, 3mg,5 mg | p. 14 |
| Azacitidine | S | Injection: 25mg/mL (With control) | p. 12 |
| Azacitidine | S | Powder for injection: 100 mg single-dose vial. Tablets: 200 mg; 300 mg | p. 13 |
| Azathioprine | S | Tablet 50mg, 75mg, 100mg | p. 12 |
| Basiliximab | S | Injection 20mg | p. 12 |
| Bevacizumab | S | Injection: 25mg/ml | p. 12 |
| Bicalutamide | S | Tablet 150mg, 50mg | p. 13 |
| Bleomycin | S | Powder for injection: 15 IU (as sulfate) in vial | p. 13 |
| Bortezomib | S | Injection: 3.5mg/vial | p. 13 |
| Cabozantinib | S | Tablet: 20 mg: 40 mg: 60 mg | p. 14 |
| Capecitabine | S | Tablet 500mg | p. 13 |
| Carboplatin | S | Injection: 10mg/mL | p. 13 |
| Cetuximab | S | Injection: 2 mg/mL | p. 13 |
| Chlorambucil | S | Tablet: 2mg | p. 13 |
| Cisplatin | S | Powder for injection: 50 mg; 10mg in vial. | p. 13 |
| Crizotinib | S | Capsule: 200mg, 250mg | p. 14 |
| Cyclophosphamide | S | Powder for injection: 500 mg; 1 g; 2 g in vial. Tablet/capsule: 25 mg; 50 mg. | p. 13 |
| Cyclosporine | S | Injection: 50 mg/mL in 1-mL ampoule; Capsule: 25 mg; 50mg; 100mg | p. 13 |
| Cytarabine | S | Injection 100mg/ml | p. 13 |
| Dabrafenib | S | Capsule: 50mg, 75mg, 150mg | p. 14 |
| Dacarbazine | S | Powder for injection: 100 mg in vial; 200mg/; 500mg | p. 13 |
| Dactinomycin | S | Powder for injection: 500 micrograms in vial | p. 12 |
| Danazol | S | Capsule 100mg Special for Haematology | p. 13 |
| Docetaxel | S | Concentrate for infusion 120mg; 80mg | p. 13 |
| Doxorubicin | S | Injection: 10mg; 20mg, 50mg | p. 13 |
| Dutasteride | S | Tablet: 0.5mg | p. 13 |
| enzalutamide | S | Tablets/Capsule: 40 mg; 80 mg | p. 12 |
| Epirubicin | S | Injection: 2 mg/mL | p. 13 |
| Erlotinib | S | Tablet: 25mg, 100mg, 150mg | p. 14 |
| Etoposide | S | Capsule: 100 mg; Injection 100 mg/mL; Injection 50mg/5mL | p. 13 |
| Everolimus | S | Tablet 0.25, 0.5mg | p. 13 |
| Febuxostat | S | Tablet 40mg; 80mg | p. 13 |
| Filgrastim | S | Injection: 5mcg | p. 13 |
| Finasteride | D | Tablet: 5mg | p. 13 |
| Fludarabine | S | lyophilized powder for Injection: 50mg/2ml Tablet: 10 mg | p. 13 |
| Folinic acid | S | Tablets: 5 mg, 10 mg, 15 mg, and 25 mg Injection: 10 mg/mL, 20 mg/mL. | p. 14 |
| Gefitinib | S | Tablet: 250mg | p. 14 |
| Gemcitabine | S | Injection: 200mg; 500mg; 1000mg | p. 13 |
| Goserelin | S | Injection 3.6mg, 10.8mg | p. 14 |
| Hydroxychloroquine | S | Tablet 200mg | p. 14 |
| Hydroxyurea | D | Capsule: 500mg | p. 14 |
| Ifosfamide | S | Injection 1g/20mL | p. 14 |
| Imatinib | S | Tablet 400mg | p. 14 |
| Interferon alfa | S | Injection: 22,500,000 I.U/1.5ml | p. 14 |
| Interleukin-2 | S | Injection: 22,000,000 I. U | p. 14 |
| Ipilimumab | S | Injection: 5mg/ml | p. 15 |
| Irinotecan | S | Injection: 180mg/mL | p. 14 |
| Leflunomide | S | Tablet: 10mg; 20mg | p. 13 |
| Lenalidomide | S | Tablet: 25mg | p. 14 |
| Lenvatinib | S | Capsule: 4 mg; 10 mg. | p. 14 |
| Letrozole | S | Tablet: 2.5 mg. | p. 15 |
| Liposomal Doxorubicin | S | Injection: 2mg/ml, 5mg/ml | p. 13 |
| Mesna | S | Injection: 100mg/mL; Tablet 400mg | p. 14 |
| Methotrexate | S | Concentrated injection: 1000 mg/10 mL. Injection: 50 mg/2 mL. Powder for injection: 50 mg (as sodium) in vial. Tablet: 2.5 mg (as sodium), 10 mg | p. 14 |
| Mycophenolate Mofetil | S | Tablet 500mg | p. 14 |
| Mycophenolate Sodium | S | Tablet: 360mg | p. 14 |
| Nivolumab | S | Injection: 10mg/mL | p. 15 |
| Oxaliplatin | S | Powder for injection: 50mg; 100mg in vial; | p. 14 |
| Paclitaxel | S | Injection 260mg vial | p. 14 |
| Pazopanib | S | Tablet 200mg, 400mg | p. 14 |
| Pegfilgrastim | S | Injection: 6 mg/0.6 mL | p. 13 |
| Pembrolizumab | S | Injection: 25mg/ml, 50 mg/ml | p. 15 |
| Pemetrexed | S | Injection: 25 mg/ml | p. 13 |
| Pertuzumab | S | Injection 30 mg/mL | p. 15 |
| Procarbazine | S | Capsule: 50 mg; 100 mg | p. 13 |
| Ranibizumab | S | Solution for Intravitreal injection: 0.3mg, 0.5mg | p. 13 |
| Rituximab | S | Injection 375 mg | p. 14 |
| Sirolimus | S | Tablet 1mg, 2mg | p. 14 |
| Sorafenib | S | Tablet: 200mg | p. 14 |
| sunitinib | S | Capsule: 12.5 mg, 25 mg, 37.5 mg, and 50 mg | p. 14 |
| Tacrolimus | S | Tablet: 0.5mg; 1mg; 2mg Ointment: 0.1%, 0.03% | p. 15 |
| Tamoxifen | S | Tablet 20mg | p. 15 |
| Tamsulosin | D | Tablet 0.4mg | p. 15 |
| Temozolomide | S | Tablet 200mg | p. 15 |
| Thalidomide | S | Tablet: 200mg | p. 15 |
| Tofacitinib | S | Tablet: 5mg, 10mg | p. 14 |
| Trametinib | S | Tablet: 0.5mg, 1mg, 2mg | p. 14 |
| Trastuzumab | S | Injection: 440mg; 150mg; 600mg; 500mg | p. 15 |
| Ulinastatin | S | Powder for injection: 100,000 IU vial | p. 15 |
| Venetoclax | S | Tablet 10 mg; 50 mg; 100 mg | p. 15 |
| Vinblastine | S | Injection: 10mg | p. 15 |
| Vincristine | S | Powder for injection: 2 mg; 5 mg (sulfate) in vial. | p. 15 |
| Vinorelbine | S | Injection: 10 mg per mL Capsules:20 mg, 30 mg, and 80 mg | p. 14 |
| Zoledronic acid | S | Injection: 4mg; 5mg | p. 15 |
Who can prescribe antineoplastics, immunosuppressives and immunomodulators in Tanzania?
It depends on each medicine's NEMLIT level. This category has medicines at levels B, D and S; level B medicines may be prescribed by specialists, medical officers, dental officers, assistant medical officers and clinical officers.
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B (listed) | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D (listed) | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Sources: Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health; DukaDawa pharmacy network. Category names as printed in the NEMLIT.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.